Remission in schizophrenia: The relationship to baseline symptoms and changes in symptom domains during a one-year study

Journal of Psychopharmacology

Volumn 23, Issue 4, 2009, Pages 436-441

  Kelly, D L ^a   Weiner, E ^a   Ball, M P ^a   McMahon, R P ^a   Carpenter, W T ^a   Buchanan, R W ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Depression; Extrapyramidal side effects; Remission; Schizophrenia; Tardive dyskinesia

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; ARTICLE; ASSESSMENT OF NEGATIVE SYMPTOMS SCALE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; MALE; NEGATIVE SYNDROME; OUTPATIENT; POSITIVE SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC TEST; QUALITY OF LIFE; REMISSION; SCHIZOPHRENIA; SYMPTOM; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BENZODIAZEPINES; DEPRESSION; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; REMISSION INDUCTION; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 65649085591     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108093883     Document Type: Article

References (41)

1. Amminger GP, Resch F, Mutschlechner R, Freidrich MH, Ernst E, (1997) Premorbid adjustment and remission of positive symptoms in first-episode psychosis. Eur Child Adolesc Psychiatry 6: 212 - 218.
2. Andreasen NC, (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry 7 (Suppl). 49 - 58.
3. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR, (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162: 441 - 449.
4. Ascher-Svanum H, Zhu B, Faries D, Kinon BJ, Kane JM, (2005) Type of symptom remission and treatment outcomes in the long-term treatment of patients with schizophrenia. Neuropsychopharmacology 30 (Suppl 1). S114.
5. Auslander LA, Jeste DV, (2004) Sustained remission of schizophrenia among community dwelling older outpatients. Am J Psychiatry 161: 1490 - 1493.
6. Barbarotto R, Castignoli G, Pasetti C, Laiacona M, (2001) Global cognitive decline in schizophrenia with remission of symptoms. Brain Cogn 46: 29 - 34.
7. Bellack AS, (2006) Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull 32: 432 - 442.
8. Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, (2005) Olanzapine treatment of residual positive and negative symptoms. Am J Psychiatry 162: 124 - 129.
9. Cassidy SL, Thaker GK, Summerfelt A, Tamminga CA, (1997) The Maryland Psychiatric Research Center scale and the characterization of involuntary movements. Psychiatry Res 70: 21 - 37.
10. Chakos MH, Alvir JM, Woerner MG, Koreen A, Geisler S, Mayerhoff D, (1996) Incidence and correlates of tardive dyskinesia in first-episode schizophrenia. Arch Gen Psychiatry 53: 313 - 319.
11. Curtis CE, Calkins ME, Grove WM, Keil KJ, Iocono WG, (2001) Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree relatives. Am J Psychiatry 158: 100 - 106.
12. Dunayevich E, Sethuraman G, Enerson M, Taylor CC, Lin D, (2006) Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes. Schizophr Res 86: 300 - 308.
13. Eaton WW, Thara R, Federman E, Tien A, (1998) Remission and relapse in schizophrenia: the Madras longitudinal study. J Nerv Ment Dis 186: 357 - 363.
14. ECDEU Assessment, Manual for Psychopharmacology (1976). In: W Guy, (ed), Clinical Global Impressions. Rockville, MD: US Department of Health, Education, and Welfare, pp. 76 - 338.
15. Emsley R, Rabinowitz J, Medori R, Early psychosis global working group (2007) Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res 89: 129 - 139.
16. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF, (2002) Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry 159: 1395 - 1402.
17. Hamilton M, (1976) Hamilton Psychiatric Rating Scale for Depression. In: W Guy, (ed). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education and Welfare, pp. 179 - 192.
18. Harrow M, Grossman LS, Jobe TH, Herbener ES, (2005) Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull 31: 723 - 734.
19. Harvey PF, Harvey PD, Bowie CR, Loebel A, (2007) The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr Res 94: 99 - 106.
20. Hawk AB, Carpenter WT, Strauss JS, (1975) Diagnostic criteria and five-year outcome in schizophrenia: a report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry 32: 343 - 347.
21. Heinrichs DW, Hanlon TE, Carpenter WT, (1984) The Quality of Life Scale: An instrument of rating the schizophrenic deficit syndrome. Schizophr Bull 10: 338 - 398.
22. Helldin L, Kane JM, Karilampi U, Norlander T, Archer T, (2006) Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 40: 738 - 745.
23. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D, (2000) Untreated initial psychosis: its relation to quality of life and symptoms remission in first-episode schizophrenia. Am J Psychiatry 157: 808 - 815.
24. Kopelowicz A, Liberman RP, Ventura J, Zarate R, Mintz J, (2005) Neurocognitive correlates or recovery from schizophrenia. Psychol Med 35: 1165 - 1173.
25. Lasser RA, Bossie CA, Gharabawi GM, Kane JM, (2005) Remission in schizophrenia: results from a 1-yar study of long-acting risperidone injection. Schizophr Res 77: 215 - 227.
26. Leucht S, Lasser R, (2006) The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39: 161 - 170.
27. Lieberman JA, Koreen AR, Chakos M, Sheitman B, Woerner M, Alvir JM, (1996) Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 57 (Suppl 9). 5 - 9.
28. Liberman RP, Kopelowicz A, (2005) Sustained remission of schizophrenia. Am J Psychiatry 162: 1763 - 1764.
29. Liberman RP, Kopelowicz A, Venture J, Gutkind D, (2002) Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry 14: 256 - 272.
30. McIntyre RS, Fallu A, Konarski JZ, (2006) Measurable outcomes in psychiatric disorders: remission as a marker of wellness. Clin Ther 28: 1882 - 1891.
31. Murray RM, Van Os J, (1998) Predictors of outcome in schizophrenia. J Clin Psychopharmacol 18 (2 Suppl 1). 2S - 4S.
32. Overall JE, Gorham DR, (1962) The Brief psychiatric rating scale. Psychol Rep 10: 799 - 812.
33. http://www.Mental
34. Remington G, Kapur S, (2005) Remission: Whatgs in a name. Am J Psychiatry 162: 2393 - 2394.
35. Resnick SG, Fontana A, Lehman AF, Rosenheck RA, (2005) An empirical conceptualization of the recovery orientation. Schizophr Res 75: 119 - 128.
36. Robinson DG, Woerner MG, McMeniman M, Mendlowitz A, Bilder RM, (2004) Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161: 473 - 479.
37. Simpson GM, Angus JW, (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212 (Suppl 44). 11 - 19.
38. Smith TE, Hull JW, Huppert JD, Silverstein SM, (2002) Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills. Schiozophr Res 55: 229 - 237.
39. Tan YL, Zhou DF, Zhang XY, (2005) Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res 74: 263 - 270.
40. Van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, (2006) Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 113: 91 - 95.
41. Yen CF, Chen CS, Yeh ML, Yen JY, Ker JH, Yang SJ, (2002) Comparison of insight in patients with schizophrenia and bipolar disorder in remission. J Nerv Ment Dis 190: 847 - 849.